7 October 2018 in Asian Journal of Pharmaceutical and Clinical Research
Objective: The present study deals with the formulation and evaluation of fast dissolving buccal films for effective treatment option in the gastroesophageal reflux disease. Methods: Esomeprazole fast dissolving buccal films are a convenient formulation of which can be taken with or without water. In the present investigation, polyvinyl alcohol and polyvinylpyrrolidone were used as film-forming agents and polyethylene glycol 400 is taken as plasticizer. Solvent evaporation method was used for the preparation of fast dissolving buccal films. Results: The films were prepared and evaluated for film thickness, folding endurance, dispersion test, drug content, and dissolution. The in vitro dissolution studies were carried out using simulated salivary fluid (pH 6.8 phosphate buffer). Conclusion: Among all the formulations, Formulation E7 was released up to 99.6% of the drug from the film within 5 min of time which exhibits faster absorption and also shows desirable characteristics of the film. The drug-excipient interaction studies WERE carried out by Fourier-transform infrared studies, differential scanning calorimetry analysis-X-diffraction studies, and scanning electron microscopic studies and the results revealed that there were no major interactions between the drugs and excipients used for the preparation of films.
7 March 2022 in International Journal of Applied Pharmaceutics
Objective: The objective of the present work is to formulate and evaluate Bosentan controlled-release microcapsules using gum karaya and polyethylene oxide as polymers, sodium alginate and calcium chloride as encapsulating material and cross-linking agent and croscarmellose sodium as superdisintegrant. Methods: Bosentan microcapsules were prepared by the ionic gelation method. The prepared microcapsules were characterized by flow properties such as angle of repose, compressibility index, particle size and encapsulation efficiency and drug release profiles. Results: The prepared microcapsules were evaluated for angle of repose, compressibility index, % drug content, encapsulation efficiency and particle size. All the flow properties were within the specified IP limits. The drug content of microcapsules prepared by ionic gelation method by varying the polymeric concentration was found in the range of 121.62±0.41 to 124.99±0.51 mg. The encapsulation efficiency of Bosentan controlled-release microcapsules was found to be in the range of 59 % to 67%. Among all the formulations prepared, formulation B14 containing equal proportions (25 mg) of gum karaya and polyethylene oxide showed about 95% of drug release over a period of 12 h and were found to be suitable for extending drug release up to 16 h. Conclusion: Bosentan controlled-release microcapsules were prepared by ionic gelation method, which is a novel formulation that is helpful in the treatment of pulmonary artery hypertension (PAH).
12 February 2025 in International Journal of Pharmaceutical Investigation
LDLakshman Kumar Dogiparthi
Lakshman Kumar Dogiparthi
BPBala Sree Sanjeevi Pusala
Bala Sree Sanjeevi Pusala
VYVamsi Abhiram Yadlapalli
+2
Introduction The goal of this study was to develop and evaluate Bosentan transdermal patches for the treatment of Pulmonary Arterial Hypertension (PAH), which is defined as an abnormally high blood pressure in the arteries that supply blood to the lungs, in patients aged three and up. Patients with PAH may find that bosentan aids their exercise performance and slows the worsening of their symptoms.Materials and Methods Using the solvent casting method, Bosentan transdermal patches were made with karaya gum and polyethylene oxide as polymers, PEG 600 as plasticizers and propylene glycol as a permeation enhancer. Folding endurance values for the manufactured Bosentan transdermal patches ranged from 95 to 100, indicating that the patches exhibited good elasticity and flexibility. -p f.Results and Discussion The optimized formulation B-10 released 94.77% of the drug for up to 12 hr, according to the drug release trial. Studies using Fourier infrared spectroscopy and differential scanning calorimetry were carried out on the pure drug, polymers and optimised formulation B-10. The results showed that the drug and polymers did not interact with one another. There were no surface cracks or defects in the patches when SEM examination was performed on the pure drug and optimised formulation B-10.
1 December 2025 in Asian Journal of Pharmaceutics
The Asian Journal of Pharmaceutics is a peer-reviewed open-access medical journal published by Medknow Publications on behalf of the B.R. Nahata Smriti Sansthan (Memorial Trust) (Mandsaur, India). Articles address topics in pharmaceutics, biopharmaceutics, pharmaceutical chemistry, pharmacognosy, pharmacology, pharmaceutical analysis, pharmacy practice, and clinical and hospital pharmacy.